AiViva BioPharma
AiViva BioPharma
  • Home
    • Overview
    • Management Team
    • Board of Directors
    • Partner With Us
    • Join Our Team
    • Scientific Overview
    • Therapeutic Areas
    • Development Pipeline
    • AIV001
    • AIV007
    • JEL™ Technology
    • Recent News
    • Upcoming Events
    • Science in the News
    • Home
    • Company
      • Overview
      • Management Team
      • Board of Directors
      • Partner With Us
      • Join Our Team
    • Areas of Focus
      • Scientific Overview
      • Therapeutic Areas
    • Pipeline
      • Development Pipeline
      • AIV001
      • AIV007
      • JEL™ Technology
    • News
      • Recent News
      • Upcoming Events
      • Science in the News
  • Home

Innovative Products, transformational treatments

Innovative Products, transformational treatmentsInnovative Products, transformational treatmentsInnovative Products, transformational treatments

Taking on challenges of discovering therapeutics to address major unmet medical needs

Innovative Products, transformational treatments

Innovative Products, transformational treatmentsInnovative Products, transformational treatmentsInnovative Products, transformational treatments

Taking on challenges of discovering therapeutics to address major unmet medical needs

  AiViva is a clinical stage biotech company led by a team of seasoned industry experts with proven track record in drug development and commercialization. AiViva has discovered novel biology to address high unmet medical needs and to transform treatment paradigms through focal therapies. Core competencies include development of novel drugs using proprietary technologies, including JEL™, in specialty therapeutic areas of dermatology, ophthalmology, urology and oncology.

Company Overview

About Us

image96

Development Strategy

AiViva deploys an efficient, risk-mitigated development strategy that addresses diseases in specialty therapeutic areas where our innovative discoveries would provide a novel pharmacotherapy or reduce the treatment burden for both patients and physicians.  

Scientific Approach

Areas of Focus

image97

Dermatology

Ophthalmology

Ophthalmology

image98

Ophthalmology

Ophthalmology

Ophthalmology

image99

Urology

Oncology

Oncology

image100

Oncology

Oncology

Oncology

image101

JEL™ Technology

Proprietary JEL™ Technology can be customized to create novel formulations enabling prolonged drug effect up to one year and expanding clinical utilities.

Learn more

Contact US

AiViva BioPharma

1300 Bristol St N, Suite 220, Newport Beach, California 92660, United States

(949) 662-1949



  • Home
  • Overview
  • Partner With Us
  • Therapeutic Areas
  • Development Pipeline
  • Recent News